Change in Boardroom
| PHARMANIAGA BERHAD |
| Date of change | 28 Dec 2020 |
| Name | LT GEN (R) DATO SRI PANGLIMA DR SULAIMAN ABDULLAH |
| Age | 65 |
| Gender | Male |
| Nationality | Malaysia |
| Designation | Director |
| Directorate | Independent and Non Executive |
| Type of change | Retirement |
Qualifications
| No | Qualifications |
Major/Field of Study |
Institute/University |
Additional Information |
|
Masters
|
Masters of Health Planning |
University of New South Wales, Sydney, Australia |
|
|
|
Masters
|
Masters of Public Health |
University of Phillipines System, Manila, Phillipines |
|
|
|
Doctorate
|
Doctor of Medicine (M.D.) |
Universiti Kebangsaan Malaysia |
|
|
|
Diploma
|
Diploma in Tropical Medicine and Hygiene |
Mahidol University, Thailand |
|
|
|
Diploma
|
Diploma in Principle of Military Medicine |
Academy of Health Sciences, Fort Sam Houston, Texas, United States of America |
|
| Working experience and occupation | Lieutenant General Dato' Seri Panglima Dr Sulaiman Abdullah (Retired) began his career with Malaysia Armed Forces (MAF) in 1982 and was commissioned to the Royal Medical and Dental Corps. During his service of more than 30 years in MAF, he held several key appointments including Commanding Officer of the 3rd Medical Battalion, Commandant of the MAF Health Training Institute, Assistant Director of Medical Services of the 4th Division, Director of Medical Services, Director Commanding Officer of the 94 Armed Forces Hospital and 96 Naval Armed Forces Hospital, and completed his illustrious career as Director General of MAF Health Services. Lieutenant General Dato' Seri Panglima Dr Sulaiman Abdullah (Retired) has vast experience in the management and supervision of MAF Health Services across Malaysia and was also involved in the development of Hospital Angkatan Tentera Tuanku Mizan Zainal Abidin. Throughout his stint with MAF, he has attended professional and military training courses in the country and abroad such as United States of America, Philippines, Thailand and Australia. His area of speciality is public health and health planning. |
| Family relationship with any director and/or major shareholder of the listed issuer | NIL |
| Any conflict of interests that he/she has with the listed issuer | NIL |
| Details of any interest in the securities of the listed issuer or its subsidiaries | NIL |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 28 Dec 2020 |
| Category | Change in Boardroom |
| Reference Number | C03-21122020-00011 |